Abstract
Purpose
We aimed to investigate frequency, time course and pathophysiology of vision loss in eyes with macula-on rhegmatogenous retinal detachment operated with vitrectomy and silicone oil tamponade.
Patients and methods
Fifteen eyes of 15 patients who had been operated with 5,000 centistoke silicone oil between 2006 and 2014 were included in a retrospective case series. Examinations included logMAR best corrected visual acuity (BCVA), visual field testing (VF), spectral domain optical coherence tomography (OCT), electrophysiology, and fluorescein angiography.
Results
Vision loss was seen in eight (53 %) eyes of 15 patients with symptomatic central scotoma, which was confirmed by VF (5/6). Preoperative median BCVA of these patients was 0.15 (0.5 to 0), prior to oil removal 0.7 (1.0 to 0.5), and 6 weeks post oil removal 1.0 (1.5 to 0.2). BCVA recovered in five patients to a median of 0.15 (0.5 to 0.1), and it remained 1.0 in three (20 %) out of 15 eyes. OCT revealed significant thinning of the foveal and parafoveal combined nerve fiber, ganglion cell and inner plexiform layers in affected eyes (mean 58.3 μm +/−13, horizontal scan through fovea, 500 μm radius) compared to their healthy fellow eyes (mean 84.5 μm +/−12.3; p < 0.01, n = 6 patients, 12 eyes) and compared to eyes with no vision loss under silicone oil.
Conclusions
We find persisting vision loss in three out of 15 patients treated for macula-on rhegmatogenous retinal detachment with silicone oil tamponade. Thinning of inner retinal layers possibly evoked by silicone oil tamponade might be a pathophysiological explanation for vision loss in these patients.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Vitrectomy is standard of care in a variety of vitreoretinal diseases. Most of the time, a tamponade is needed. The most common types are gas or air tamponades [1]. In more severe cases like retinal detachment with proliferative vitreo-retinopathy [2] or proliferative diabetic retinopathy with complex retinal pathology [3], silicone oil is used. However, some surgeons promote the primary use of silicone oil even in uncomplicated macular hole surgery [4, 5]. The safety and efficacy of silicone oil in ophthalmic surgery has been demonstrated in many studies during the last decades [6, 7]. A potential toxicity of silicone oil to the human retina has been denied [8, 9]. Only a few authors have discussed a harmful effect of silicone oil to animal and human retinal structures, especially in long-term use [10–12]. Recently, unexpected and unexplained central vision loss has been described in patients who underwent vitrectomy with silicone oil tamponade [13–16]. This phenomenon can occur either during tamponade or after silicone oil removal, and it is known to many surgeons, though little is published. The underlying pathology of this idiopathic vision loss is unclear. Thinning of inner retinal layers in affected eyes and intraretinal microcysts have been discussed as a possible pathomechanism theories [13, 17].
An explanation for this phenomenon is difficult to find, since many variables can contribute to vision loss, e.g. involvement of the macula, extend of the retinal detachment, intra- and postoperative intraocular pressure, the number of reoperations, and the experience level of the surgeon. Therefore we tried to minimize the variables by examining a homogenous group. We provide retrospective data of 15 patients with macula-on retinal detachment, who underwent vitrectomy with the use of silicone oil tamponade at our clinic. The macula remained attached during the entire follow-up period. We analyzed the frequency, time course and underlying pathology of vision loss under silicone oil tamponade.
Patients and methods
We analyzed data of all patients, who were vitrectomized between 2006 and 2014 at our center. During this time period, about 5,400 vitrectomies were performed. Approximately 900 of these cases received a silicone oil tamponade with 5,000 centistoke silicone oil. Vitrectomy was carried out in a standardized way. After vitrectomy and following reattachment of the retina by means of perfluorocarbon liquid (PFCL) and laser or cryo coagulation of retinal holes, PFCL was directly exchanged with silicone oil. Intraocular pressure was documented to be within normal limits during the operation procedure. Indications for vitrectomy with silicone oil tamponade were: recurrent retinal detachment 47 %, retinal detachment with macular involvement partly with proliferative vitreoretinopathy 28 %, retinal detachment in high myopia 6 %, high-risk proliferative diabetic retinopathy with vitreal bleeding and/or tractional retinal detachment 5 %, traumatic eye rupture 5 %, acute retinal necrosis 2 %, macula-on retinal detachment 2 %, other 5 %. Out of 900 patients who received vitrectomy with silicone oil tamponade for various indications, only 18 patients (2 %) had rhegmatogenous retinal detachment without macular involvement, three of which had to be excluded due to recurrent retinal detachment (n = 1) or macular edema (n = 1) and epiretinal gliosis (n = 1) during follow-up. Fifteen patients fulfilled the inclusion criteria of rhegmatogenous retinal detachment with an attached intact macula before, during and after vitrectomy. Only these 15 were included into the study.
Best corrected logarithmic minimum angle of resolution (logMAR) visual acuity (BCVA) and a full ophthalmological examination were carried out in all patients preoperatively at the date of diagnosis, postoperatively, 6 weeks after operation, before oil removal, after oil removal, 6 weeks after oil removal and at latest follow-up (median 36 months, range 4 to 82).
Additionally, nine out of 15 patients were reexamined at a median follow-up of 48 months (range 14 to 70 months). In these nine patients, 10° and 30° central visual field (VF) analysis (Humphrey Filed Analyzer Model 750, Carl Zeiss, USA), macular and peripapillary retinal layer measurements by spectral domain optical coherence tomography (OCT) (Spectralis®, Heidelberg Engineering, Heidelberg, Germany), single retinal layer discrimination in horizontal macular scans (Heidelberg Eye Explorer® Segmentation EditorTM, Heidelberg Engineering) and the thickness of the retinal nerve fiber layer in peripapillary scans using Axonal Single Exam Report OU with FoDiTM (Heidelberg Engineering) were carried out. Further, multifocal electro retinogramme (ERG) and visually evoked potentials (VEP) were done in these nine patients (RETI-port/scan21, Roland Consult, Brandenburg a. d. Havel, Germany). In two of 15 patients, ERG could be carried out before oil removal. Fluorescein angiography (FLA) was done in three of 15 patients (Heidelberg Engineering). The treated eyes were compared intra-individually to the fellow control eye.
Statistical analysis was carried out with the programme “R” (www.r-project.org).
Written consent was obtained from all reexamined patients. For retrospective data, formal consent is not required. All measurements followed the recommendations of the university ethics committee (D453/14) in accordance to the declaration of Helsinki and German federal law.
Results
Demographics
Fifteen eyes of 15 patients were included. Median age was 61 years (range 45 to 75 years), and three women and 12 men were examined.
Vision
Figure 1 shows the time course of visual acuity before, during and after silicone oil tamponade. Vision loss was noted in eight (53 %) out of 15 eyes of 15 patients, all complaining about a central scotoma, confirmed by central visual field analysis in five out of six patients examined. Before silicone oil instillation, median logMAR BCVA of the eight patients with vision loss under silicone oil was 0.15 [20/28 Snellen equivalent] (range 0.5 [20/63] to 0.0 [20/20]). Before oil removal, BCVA of these eight patients was 0.7 [20/100] (1.0 [20/200] to 0.5 [20/63]), and 6 weeks after oil removal it was 1.0 [20/200] (1.5 [20/600] to 0.2 [20/32]). BCVA recovered in five patients to a median of 0.15 [20/28] (0.5 [20/63] to 0.1 [20/25]) at latest follow-up (>1 year), but remained 1.0 [20/200] in three patients. In four patients, vision loss happened within the first 6 postoperative weeks; all of these recovered. The other four patients complained about vision loss within the first 3 months; three of these did not recover. Vision loss always occurred before oil removal. The time point of oil removal did not affect the vision outcome.
Clinical examinations
All patients presented with macula-on retinal detachment. Eleven of 15 patients had rhegmatogenous retinal detachment with multiple peripheral holes at initial presentation. Four of 15 patients had giant tear retinal detachment. The time of retinal detachment was less than 6 h in all cases. Vitreal bleeding was present in two cases, resulting in a reduced preoperative visual acuity. The macula stayed attached at all times before, during and after operations.
In all patients, slit lamp examination did not show any pathological finding at initial presentation or at follow-up visits. The postoperative healing process was uneventful in all cases. Intraocular pressure was normal at all times in all patients. Optic media were clear at all times. Five out of eight patients with vision loss under silicone oil were initially pseudophacic, and three patients (BCVA recovered in two of these) received phacoemulsification with intraocular lens implantation in a combined operation with the oil explanation. Funduscopy showed no macular abnormalities. Optic disc was generally vital in all patients; temporal paleness was noticed in two, both with vision loss under silicone oil. A myopic cone was seen in 12 of 15 patients.
OCT and macula
Figure 2a shows the mean thickness of the nerve fiber, ganglion cell and inner plexiform layers (NFL, GCL, IPL) in a horizontal OCT scan through the macula of eyes with vision loss under silicone oil in comparison to their fellow eyes. It reveals significant (p < 0.01, n = 6 patients) thinning of the NFL, GCL and IPL 500 μm temporal and nasal from the fovea (mean 58.3 μm +/−13), when compared to the healthy fellow eyes (mean 84.5 μm +/−12.3). An example of such a scan is given in Fig. 3. This thinning was not seen (p = 0.08, n = 3 patients) in horizontal OCT scans through the macula of eyes without vision loss under silicone oil (mean 93.5 μm +/−7.2, 500 μm temporal and nasal from the fovea, Fig. 2b). There was even a trend towards thickened inner retinal layers when compared to the healthy fellow eyes (mean 77.8 +/−15.1, 500 μm temporal and nasal from the fovea). A comparison between eyes with continuing vision loss and those with vision recovery was not possible due to limited case numbers. All other retinal layers did not show any significant difference (p > 0.05) between operated eyes with or without vision loss and their fellow eyes.
Significant thinning of the combined NFL, GCL and IPL was mainly obvious in the macular region, especially in a parafoveal ring of 500 μm radius (see Fig. 3). Microcysts were seen in five of six eyes with vision loss under silicone oil, usually in the inner plexiform and inner nuclear layers. These cysts appear to be hypo reflective, as shown in Fig. 3. No microcysts were seen in eyes without vision loss under silicone oil.
OCT and optic disc
Optic disc OCT measurements were carried out in six out of eight patients with vision loss under silicone oil. Two of these six patients had no vision recovery, while the other four patients experienced vision recovery during the follow-up period. Optic disc OCT revealed thinning of the NFL in the papillo-macular bundle in those two patients (33 μm and 35 μm, respectively [normal thickness 56 μm]) who had no vision recovery, as shown in Fig. 4. Thinning of the NFL in the papilla-macular bundle was also seen in one patient (33 μm), with vision loss under silicone oil and following vision recovery. This patient, however, had the worst vision in the vision recovery group (BCVA 0.5 logMAR [20/63 Snellen equivalent]). The other three patients with vision loss under silicone oil and vision recovery had no thinning of the NFL in the papillo-macular bundle. Patients without vision loss under silicone oil had normal OCT findings.
Multifocal ERG
Nine patients were examined by multifocal ERG after silicone oil removal. Six of those nine patients had vision loss under silicone oil, three did not experience vision loss. All nine patients had normal multifocal ERG findings at the median follow-up of 48 months (range 14 to 70 months) after oil removal. In two patients, both with vision loss under silicone oil, multifocal ERG was additionally done before oil removal. It showed a reduction in electrophysiological activity of all stimulation areas before oil removal, most likely due to the insulation effect of the silicone oil. Six weeks after oil removal, the electrophysiological activity of central stimulation areas was still reduced, although the insulation effect of silicone oil was absent, as depicted in Fig. 5. The amplitudes improved over time (follow-up 7 to 12 months after oil removal), but vision remained 0.1 logMAR [20/200]. VEP was physiological in all examined eyes (9/9).
Fluorescein angiography
FLA was carried out in three out of eight eyes with vision loss under silicone oil. One patient was examined 1 month after oil removal. No perfusion abnormalities were seen. The second patient had a normal FLA 4 days after oil removal. The third patient had an FLA 1 day before oil removal. Retinal perfusion was intact and there were no pathological findings.
Discussion
Vision
During a time period of 9 years, about 900 vitrectomized patients received a silicone oil tamponade at our center. Only 15 of these had macula-on rhegmatogenous retinal detachment with an attached intact macula before, during and after operations. All of these patients were included. Eight patients out of this group of 15 experienced vision loss with central scotoma, three of whom have never recovered even years after oil removal. This means that 20 % of these patients suffer from vision loss with permanent poor vision. In a similar, though smaller, consecutive case series with nine eyes of nine patients, Christensen describes vision loss in one-third of the patients after silicone oil removal [13]. Moya et al. report a similar high incidence of vision loss in ten of 20 fovea-sparing giant tear retinal detachment patients, who underwent vitrectomy with silicone oil tamponade and following oil removal. Five (5/14) of these cases had vision recovery [16].
Many authors argue that vision loss appears after the removal of silicone oil [13, 18–22]. Others present cases of vision loss during silicone oil tamponade [14, 17]. In our case series, all patients had vision loss during the time of silicone oil tamponade. Vision loss occurred within the first 6 postoperative weeks in four out of eight eyes affected. The other four patients suffered from vision loss later, within the first two to three postoperative months. Therefore, the length of the tamponade does not seem to affect vision loss. However, an early vision loss under silicone oil seems to be of better prognosis. A long-term follow-up of more than 1 year can be recommended, since vision may recover over such a time period after oil removal.
A time dependency of silicone oil removal concerning visual outcome remains unclear. Early oil removal is discussed to be of better prognosis [13, 23]. In our case series, the time of silicone oil removal does not affect visual outcome.
OCT
High resolution time domain or spectral domain OCT have revealed thinning of inner retinal layers and intraretinal microcysts [13, 17, 24]. We utilized OCT based retinal layer thickness analysis and compared the treated eyes intra-individually to the untreated control fellow eyes. We show a significant reduction in thickness of the combined NFL, GCL, IPL of the inner parafoveal ring in vision loss eyes compared to their fellow eyes. This is not seen in eyes without vision loss under silicone oil. All other retinal layers are anatomically normal in affected and unaffected eyes. We assume that the reduction of the retinal ganglion cell associated layers (NFL, GCL and IPL) is a consequence of ganglion cell death, possibly due to silicone oil tamponade.
Apart from the clear thinning of the inner retinal layers, there are hyporeflective intraretinal cysts possibly of degenerative origin or filled with silicone oil. Those findings can only be detected in eyes with vision loss. Intraretinal cysts have been described before and shown to be filled with silicone oil droplets [25–30]. However, these hyporeflective intraretinal cysts are not as clearly detectable.
Latest OCT measurements of peripapillary NFL in patients who underwent vitrectomy with silicone oil tamponade reveal thickening of the NFL in operated eyes, compared to fellow eyes [31]. In our study, NFL in peripapillary OCT scans of patients without vision loss (3/3) were normal. In contrast, patients with permanent vision loss under silicone oil had thinning of the NFL in the papillo-macular bundle, likewise shown by other authors [31], underlining again ganglion cell death of the inner parafoveal ring region.
Electrophysiology
Our limited data suggests an initially pathological multifocal ERG with a reduction in central stimulation areas in patients with vision loss after silicone oil removal. However, at long-term follow-up (many months, up to years after oil removal), multifocal ERG is nearly physiological and comparable to the fellow eye. Cazabon carried out multifocal ERG in his case series shortly after oil removal, showing a reduction in central stimulation areas [18]. He did not document the long-term follow-up. ERG is a function of photoreceptor integrity. We interpret the recovery of multifocal ERG recordings as recovery of photoreceptor functionality, without ganglion cell recovery. This supports our theory of exclusive ganglion cell death in eyes with vision loss, leaving the photoreceptors untouched.
Pathophysiology
Our data clearly show a reduction of ganglion cells in the parafoveal retina of patients with vision loss, who were treated with vitrectomy and silicone oil tamponade for macula-on retinal detachment. Toxicity of silicone oil to retina bound cells is a widely discussed mechanism. In vitro and in vivo studies have proposed a harmful effect of silicone oil to retinal structures, and toxic substances in removed silicone oil have been described [8–12]. Following this theory, silicone oil has to be in close proximity to retinal structures to be harmful. Intraretinal and intra optic nerve silicone oil droplets have been described [25, 29, 32]. Epiretinal or intraretinal silicone oil might damage ganglion cells directly. Also, microglia within the retina could be activated by silicone oil, leading to inflammatory processes with consecutive cell death. All these cells are in direct proximity to the silicone oil surface. If silicone oil directly or indirectly damages ganglion cells, it remains, however, unclear why first of all, not all eyes are affected, and why second of all, thinning of the combined NFL, GCL, IPL is mainly found in the inner parafoveal ring. We have no explanation for the fact that not all eyes are affected. A further study to correlate the amount of silicone oil within the eye bulb and the number of patients with vision loss under silicone oil might be helpful to find an answer to this question. The fact that a reduction of NFL, GCL and IPL thickness is mainly seen in the inner parafoveal ring might be due to the fact that the by far largest amount of ganglion cells is found in the inner 4 to 5° parafoveal ring [33]. Changes in the number of ganglion cells would be most prominent here.
Enhanced phototoxicity, especially at the time of silicone oil removal, is a different discussed mechanism of vision loss [34]. Since all of our patients experience vision loss before oil removal, we do not support this theory.
Conclusion
Silicone oil is one of the best-known intraocular tamponades and it is widely used and considered to be safe. In many vitreoretinal surgery cases, there is no alternative to silicone oil. Our data suggests that there are unexplained cases of vision loss under silicone oil tamponade and that the number of these cases might be underestimated.
Patients with vision loss under silicone oil treated for macula-on retinal detachment show a significant thinning of the inner retinal layers compared to the untreated fellow eyes. We conclude that ganglion cell death might be a reason for vision loss in these patients. The underlying pathophysiological mechanisms remain unclear. Pathomechanism directed in vivo and in vitro studies and a comparison to patients who received a gas tamponade are needed.
We suggest to consider the possibility of vision loss if utilizing silicone oil and to limit its use to patients with a complicated vitreo-retinal situation. OCT monitoring might be helpful to detect early changes in inner retinal layer thickness and remove silicone oil early.
References
Rizzo S, Barca F (2014) Vitreous substitute and tamponade substances for microincision vitreoretinal surgery. Dev Ophthalmol 54:92–101
Schwartz SG, Flynn HW Jr, Lee WH, Wang X (2014) Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev 2, CD006126
Shen YD, Yang CM (2007) Extended silicone oil tamponade in primary vitrectomy for complex retinal detachment in proliferative diabetic retinopathy: a long-term follow-up study. Eur J Ophthalmol 17(6):954–960
Schurmans A, Van Calster J, Stalmans P (2009) Macular hole surgery with inner limiting membrane peeling, endodrainage, and heavy silicone oil tamponade. Am J Ophthalmol 147(3):495–500
Van De Moere A, Stalmans P (2003) Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage, and silicone oil tamponade. Am J Ophthalmol 136(5):879–887
Gonvers M (1985) Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 100(2):239–245
Federman JL, Schubert HD (1988) Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 95(7):870–876
Inoue M, Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y (2009) Effects of perfluorocarbon liquids and silicone oil on human retinal pigment epithelial cells and retinal ganglion cells. Retina 29(5):677–681
Lucke KH, Foerster MH, Laqua H (1987) Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol 104(6):624–633
Bambas B, Eckardt C, Vowinkel E, Kruse H (1995) Toxic substances with silicone oil after intraocular injections. Ophthalmology 92(5):663–667
Papp A, Kiss EB, Timar O, Szabo E, Berecki A, Toth J, Pali J (2007) Long-term exposure of the rabbit eye to silicone oil causes optic nerve atrophy. Brain Research Bulletin 74(1-3):130–133
Pastor JC, Lopez MI, Saornil MA, Refojo MF (1992) Intravitreal silicone and fluorosilicone oils: pathologic findings in rabbit eyes. Acta Ophthalmol (Copenh) 70(5):651–658
Christensen UC, la Cour M (2012) Visual loss after use of intraocular silicone oil associated with thinning of inner retinal layers. Acta Ophthalmol 90(8):733–737
Rani PK, Raman R, Bhende P, Sharma T (2005) Visual loss may be due to silicone oil tamponade effect rather than silicone oil removal. Br J Ophthalmol 89(12):1667
Williams PD, Fuller CG, Scott IU, Fuller DG, Flynn HW (2008) Vision loss associated with the use and removal of intraocular silicone oil. Clin Ophthalmol 2(4):955–959
Moya R, Chandra A, Banerjee PJ, Tsouris D, Ahmad N, Charteris DG (2015) The incidence of unexplained visual loss following removal of silicone oil. Eye 29(11):1477–1482
Shalchi Z, Mahroo OA, Shunmugam M, Mohamed M, Sullivan PM, Williamson TH (2015) Spectral domain optical coherence tomography findings in long-term silicone oil-related visual loss. Retina 35(3):555–563
Cazabon S, Groenewald C, Pearce IA, Wong D (2005) Visual loss following removal of intraocular silicone oil. Br J Ophthalmol 89(7):799–802
Herbert EN, Liew SH, Williamson TH (2005) Visual loss after silicone oil removal. Br J Ophthalmol 89(12):1667–1668
Michel G, Meyer L, Naoun O (2009) Sudden visual loss following silicone oil removal: three patients treated for giant retinal tear. J Fr Ophtalmol 32(2):104–111
Newsom RS, Johnston R, Sullivan PM, Aylward GB, Holder GE, Gregor ZJ (2004) Sudden visual loss after removal of silicone oil. Retina 24(6):871–877
Toso A, Cappello E, Morselli S (2014) Unexpected and permanent central visual loss after removal of intraocular silicone oil. Clin Ophthalmol 8:1831–1836
la Cour M, Lux A, Heegaard S (2010) Visual loss under silicone oil. Klinische Monatsblatter fur Augenheilkunde 227(3):181–184
Caramoy A, Droege KM, Kirchhof B, Fauser S (2014) Retinal layers measurements in healthy eyes and in eyes receiving silicone oil-based endotamponade. Acta Ophthalmol 92(4):e292–297
Errera MH, Liyanage SE, Elgohary M, Day AC, Wickham L, Patel PJ, Sahel JA, Paques M, Ezra E, Sullivan PM (2013) Using spectral-domain optical coherence tomography imaging to identify the presence of retinal silicone oil emulsification after silicone oil tamponade. Retina 33(8):1567–1573
Kiilgaard JF, Milea D, Logager V, la Cour M (2011) Cerebral migration of intraocular silicone oil: an MRI study. Acta Ophthalmol 89(6):522–525
Kirchhof B, Tavakolian U, Paulmann H, Heimann K (1986) Histopathological findings in eyes after silicone oil injection. Graefes Arch Clin Exp Ophthalmol 224(1):34–37
Krzystolik MG, D’Amico DJ (2000) Complications of intraocular tamponade: silicone oil versus intraocular gas. Int Ophthalmol Clin 40(1):187–200
Mrejen S, Sato T, Fisher Y, Spaide RF (2014) Intraretinal and intra-optic nerve head silicone oil vacuoles using adaptive optics. Ophthalmic surgery, lasers & imaging retina 45(1):71–73
Wickham L, Asaria RH, Alexander R, Luthert P, Charteris DG (2007) Immunopathology of intraocular silicone oil: enucleated eyes. Br J Ophthalmol 91(2):253–257
Zoric Geber M, Bencic G, Vatavuk Z, Ivekovic R, Friberg TR (2014) Retinal nerve fibre layer thickness measurements after successful retinal detachment repair with silicone oil endotamponade. Br J Ophthalmol 99(6):853–8
Shields CL, Eagle RC Jr (1989) Pseudo-Schnabel’s cavernous degeneration of the optic nerve secondary to intraocular silicone oil. Archives of ophthalmology 107(5):714–717
Oppel O (1967) Studies on the distribution and number of retinal ganglion cells in the human. Graefes Arch Clin Exp Ophthalmol 172(1):1–22
Dogramaci M, Williams K, Lee E, Williamson TH (2013) Foveal light exposure is increased at the time of removal of silicone oil with the potential for phototoxicity. Graefes Arch Clin Exp Ophthalmol 251(1):35–39
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The study was funded internally by the department’s research budget. No external or third party funding was received for this study. The authors have nothing to disclose.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Tode, J., Purtskhvanidze, K., Oppermann, T. et al. Vision loss under silicone oil tamponade. Graefes Arch Clin Exp Ophthalmol 254, 1465–1471 (2016). https://doi.org/10.1007/s00417-016-3405-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3405-z